
SynBioBeta 2026 Speaker
Chong Wing Yung
LBNL
Program Manager
Chong leads the Cellular Intelligence and BioAnalytics (CIBA) research group, where he develops the analytical tools and AI/ML modeling frameworks needed to construct digital twins of cells for biodesign. Before joining ABPDU, he spent 14 years at Agilent Technologies, most recently as a Distinguished Scientist and Senior Program Director. In this role, he served as Chair of the Global Grants Board, directing four international teams in the evaluation of over 600 research proposals from leading global investigators to guide strategic innovation across the full breadth of Agilentโs technology portfolio.His leadership at Agilent Research Labs pioneered novel metrology standards, advanced 3D cell culture capabilities, and algorithmic upgrades to improve sensitivity on the Seahorse live-cell analysis platform, as well as the development of commercial CRISPR technologies. Earlier in his career at Genentech, Chong conducted GMP scale-up operations and research for landmark antibody-based pharmaceuticals, including Avastin, Herceptin, and Rituxan.An elected member of the National Academy of Engineeringโs U.S. Frontiers of Engineering, Chong holds 16 patents (issued and pending) and serves on multiple university advisory boards. He is an Adjunct Professor of Physics at West Valley College and earned his Ph.D. in Chemical & Biomolecular Engineering from the University of Maryland, followed by a CIMIT Fellowship at Harvard Medical School-Wyss Institute and Children's Hospital Boston.



Reagan
Jarvis
Anocca AB
CEO, Co-founder

Alex
Rives
CZI Biohub
Head of Science

Karenโฏ
Akinsanya
Schrodinger
President, R&D โ Therapeutics

Christopher
Arendt
Takeda
CSO, Head of Research

Stef
van Grieken
Cradle
CEO

Michael
Koeris
DARPA
Director, BTO

Jennifer
Dionne
Pumpkinseed
CEO

Daniyal
Hussain
GSK
Exec. Dir., Tech BD

Cynthia
Hong
Novartis
Dir., Search & Evaluation
SynBioBeta 2027 May 3-6, San Jose, California


